COVID-19 susceptibility and severity for dyslipidemia: A mendelian randomization investigation

Background: The severe acute respiratory syndrome coronavirus in 2019 (COVID-19) is still spreading and causing deaths worldwide, which further increased the burden of chronic diseases. Dyslipidemia is a common metabolic syndrome, which is a major risk factor for cardiovascular disease. However, stu...

Full description

Bibliographic Details
Main Authors: Yi Liang, Liang Liu, Bo Liang
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023074558